NICE publishes single guideline for managing COVID-19
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
All NICE products on COVID-19. Includes any guidance and advice.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (10)
Review the evidence across broad health and social care topics.
Reviews the clinical and cost-effectiveness of new treatments.
Review new diagnostic technologies for adoption in the NHS.
Review the best available evidence for selected medicines.
Review the evidence and likely costs of medical devices and technologies.
Guidance, quality standards and advice being developed.
Technology appraisal guidance which has been proposed for development.
We also have resources to help local partnerships tackle their priorities. For advice specific to your area, contact your local NICE field team.
We've brought together guidance, resources and other information that may help you.
We've updated our summaries of current evidence for primary care professionals with some information about COVID-19. This is largely based on guidance from Public Health England.
We're part of the research to access pathway for investigational drugs for COVID-19 (RAPID-C19), a collaboration that aims to get treatments to patients quickly and safely.
We're hosting these guides while we integrate the content into our guidance. They aim to help hospital departments continue essential care for patients while supporting the wider hospital and community to care for people with COVID-19.
A guide for internal developers and external collaborators on assessing the quality of wider sources of data and evidence in our guidance.
A 3-stage approach to help anyone working on testing for COVID-19 to collect the best possible data and evidence while tests are being quickly developed and validated.
A guide to evidence collection for medicines, plus free scientific advice for researchers developing novel diagnostics or therapeutics for COVID-19.
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
NICE, PHE and SACN have today published rapid guidance on vitamin D for COVID-19.
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 8 shared learning examples for this topic: